Isosorbide mononitrate/arginine - Angiogenix

Drug Profile

Isosorbide mononitrate/arginine - Angiogenix

Alternative Names: ACCLAIM

Latest Information Update: 24 Jun 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Angiogenix Inc
  • Class Basic amino acids; Diamino amino acids; Essential amino acids; Ischaemic heart disorder therapies; Organic nitrates; Sugar alcohols; Vasodilators
  • Mechanism of Action Nitric oxide donors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Angina pectoris

Most Recent Events

  • 08 Feb 2005 Data from a media release have been added to the Ischaemic Heart Disease therapeutic trials section
  • 31 Jan 2005 Angiogenix has completed a phase II trial in chronic angina pectoris in 7 countries
  • 29 Jun 2004 Nitrate/arginine is available for licensing (http://www.angiogenix.com)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top